Hederasal Max

Dry extract of Hederae folium, the active ingredient in Hederasal Max, is a botanical preparation presented as a dry ethanol‑based extract (Der 4‑8:1) for oral use. It is traditionally employed to support respiratory function and to aid mucus clearance in both adults and children with cough or bronchial irritation.

GNH USA supplies Hederasal Max as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, with the product sourced from the European Union market, ensuring quality and regulatory compliance.

Hederasal Max, containing dry extract of Hederae folium, is used as a botanical expectorant and mucolytic in respiratory conditions.

Acute cough: helps loosen mucus and facilitates expectoration in upper respiratory infections. Bronchitis: supports airway clearance and reduces cough frequency. Chronic obstructive pulmonary disease (COPD): adjunct therapy to improve sputum removal. Asthma (as adjunct): may aid mucus clearance when used under medical supervision.

Adverse reactions may occur with oral administration of ivy leaf extract.

Common Side Effects: - Gastrointestinal discomfort: mild nausea or stomach upset. - Altered taste: transient bitter or metallic sensation. - Skin rash: mild erythema or itching at the site of contact. - Dizziness: occasional light‑headed feeling. - Headache: mild to moderate intensity. - Diarrhoea: loose stools in sensitive individuals.

Serious or Rare Side Effects: - Bronchospasm: unexpected tightening of airway muscles. - Anaphylaxis: severe allergic reaction with swelling, breathing difficulty. - Hepatic enzyme elevation: abnormal liver function tests. - Cardiac arrhythmia: irregular heartbeat reported rarely. - Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Hematologic changes: unexplained bruising or bleeding.

When considering Hederasal Max, several safety measures are recommended.

Pregnancy: consult a healthcare professional; safety not established. Breastfeeding: use with caution; limited data available. Pediatric use: dosage and suitability must be determined by a physician. Asthma patients: monitor for possible bronchospasm. Drug interactions: avoid combining with other mucolytic or expectorant products without medical advice. Store at ambient temperature: keep in the original container, protect from moisture and light.

Ivy leaf extract may interact with other medicines; awareness of potential effects is important.

Major Interactions (Avoid): - Co‑administration with other herbal expectorants containing saponins may increase gastrointestinal irritation. - Concurrent use with potent bronchodilator inhalers may rarely precipitate excessive bronchial relaxation.

Moderate Interactions (Monitor Closely): - Use with antitussive agents may reduce the intended expectorant effect. - Combination with anticoagulants could modestly raise bleeding risk. - Concomitant antihistamines may enhance sedation. - Interaction with certain antibiotics (e.g., macrolides) may alter metabolism; monitor therapeutic response.